Slovenia to launch generic version of Viagra

Jul 31, 2009

Krka, the biggest drugmaker in Slovenia, said Friday that its generic version of the impotency drug Viagra would be launched in September and priced 30 percent cheaper than the original.

"We'll launch it first in Slovenia and later on, when the patents expire in other countries (in 2012), we'll offer it in central, eastern and western Europe as well," Krka chief executive Joze Colaric told the Internet news site, Zurnal24.

Russia, in particular, was seen as an important market.

Krka's version of the erectile dysfunction drug would be marketed under the name "vizarsin" and, unlike the blue pills made by US drug giant , would be white in colour, Colaric said.

The European Medicines Agency EMEA authorised the marketing of Krka's generic version of on June 25.

(c) 2009 AFP

Explore further: Study finds sharp rise in opioid treatment among pregnant women

add to favorites email to friend print save as pdf

Related Stories

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

European office withdraws Nexium patent

Dec 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

Viagra may aggravate sleep apnea

Sep 25, 2006

A study done in Brazil indicates a single dose of the erectile dysfunction drug Viagra may aggravate sleep apnea.

Cialis may have one-a-day version

Jun 13, 2006

U.S. drug giants Eli Lilly and Icos Corp. plan to seek regulatory approval to market a one-a-day version of their impotence-fighting drug Cialis.

Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

Recommended for you

FDA proposes accelerated medical device approval plan

21 hours ago

(HealthDay)—The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical ...

Targeting drugs to reduce side effects

Apr 23, 2014

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

User comments : 0

More news stories

New breast cancer imaging method promising

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Breast cancer replicates brain development process

New research led by a scientist at the University of York reveals that a process that forms a key element in the development of the nervous system may also play a pivotal role in the spread of breast cancer.

Research proves nanobubbles are superstable

The intense research interest in surface nanobubbles arises from their potential applications in microfluidics and the scientific challenge for controlling their fundamental physical properties. One of the ...

Using antineutrinos to monitor nuclear reactors

When monitoring nuclear reactors, the International Atomic Energy Agency has to rely on input given by the operators. In the future, antineutrino detectors may provide an additional option for monitoring. ...